Extended Data Fig. 9: Mutations identified in histiocytic sarcoma (HS) (n = 6 patients).
From: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Results of whole exome and targeted DNA and RNA sequencing of non-LCH neoplasms. Each patient is represented in one column. Diagnosis (HS), age category, and sequencing method are in the first 3 rows. Somatic mutations identified are in the lower rows and subdivided based on mutations known to activate kinases or involve a diverse array of co-occurring pathways (shown on the right).
